A rare localization of giant symplastic leiomyoma: Perianal region

Giant symplastic leiomyoma of the gluteal region is a rarely seen situation. It is accepted as a benign illness. A 36-year- old woman presented to general surgery clinic because of a mass on her right thigh. On physical examination, there was a 7 x 6 cm mass that was mobile and bulging up from the surface of skin, 3 cm from her anus. Pathologic examination revealed symplastic leiomyoma. Leiomyomas are benign smooth muscle tumors. After excision, dermal lesions have a 40% recurrence rate. Even if mitotic activity can be shown microscopically, follow-up is important and unnecessary treatment for symplastic leiomyoma must be avoided. [Arch Clin Exp Surg 2015; 4(2.000): 101-102

Topikal hemostatik ajanların travmalı olgularda güncel kullanım esasları

ÖZETSivil ve askeri travmalarda önlenebilir ölümlerin en sık nedeni kanamalardır. Özellikle ekstremitelerde meydanagelen yaralanmalarda basit kanama kontrolü ve turnike uygulanabilirken aksiller ve femoral bölge yaralanmalar›nda hemostaz zor sa¤lanmaktad›r. Bu yaz›da posttravmatik kanamal› olgularda kullan›lmas› önerilen topikal hemostatik ajanlar›n literatür eflli¤inde gözden geçirilmesi amaçland›. Topikal hemostatik ajanlarla ilgili mevcut bilgilerin,az say›da olgu sunumuna, ço¤unlu¤u deneysel çal›flmalardan elde edilen verilere ve sahraya ait baz› kiflisel yorumlara dayand›¤›, ürünler aras›nda klinik kullan›m›na ait ileriye dönük randomize kontrollü çal›flmalara rastlanmad›¤›gözlendi. Kanamaya ba¤l› geliflen mortaliteyi azaltmaya yönelik topikal hemostat uygulamas›na dair de¤erlendirmelerin yüksek kan›t düzeyli çal›flmalar ile desteklenmesine ihtiyaç duyulmaktadır. Anahtar sözcükler: Topikal hemostat; kanamaSUMMARYHemorrhage is the most common cause of preventable deaths both in civilian and military trauma. Simple hemorrhage control and tourniquets can be applied in extremity injuries but hemostasis in the axillary and femoralregion is rather challenging. In this study, results on the efficacy of topical hemostatic agents in post-traumatichemorrhages reported in the literature are reviewed. As conclusion, current information on topical hemostaticagents depend upon a few case reports, data from mostly experimental studies and subjective evaluations in thefield, but there are no prospective, randomized studies with control group. Evaluations regarding the use of topical hemostatic agents to reduce the mortality need to be supported by studies with higher level of evidence.Key words: Topical hemostat; hemorrhage.</p